Back to top
more

Janus Henderson Global Life Sciences Fund - A Shares: (MF: JFNAX)

(NASDAQ Mutual Funds) As of Jan 14, 2026 06:22 PM ET

$80.76 USD

+0.93 (1.16%)

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

2-Buy of 5   2      

View All Zacks Mutual Fund Rank #1's

Latest Performance as of Dec 31, 2025

Total Return %* Percentile Rank Objective
YTD 24.59 25
3 months 18.59 15
6 months 28.32 25
1 Year 24.59 25
3 Year 11.40 26
5 Year 7.45 13
10 Year 9.94 10

* Annual for three years and beyond.

Zacks Premium Research for JFNAX

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Buy 2
MF Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

% Unrealized Gain 35.89
% Yield 0.31
% SEC Yield NA
Net Assets (Mil $) 12/31/2025 279.06
% Turnover 12/31/2025 30.00

Risk

3 Year 5 Year 10 Year
Beta 0.69 0.63 0.77
Alpha -4.34 -2.15 -1.32
R Squared 0.30 0.40 0.53
Std. Dev. 15.08 15.06 16.14
Sharpe 0.50 0.35 2.00

Sector / Country Weightings

As of 12/31/2025 % of Portfolio
Health 67.38
Other 9.56
Finance 9.37
Services 4.51
Retail Trade 4.18
Technology 2.68
Industrial Cyclical 2.32

Portfolio Holdings

Top Equity Holdings
(As of 9/30/2025)
% of Portfolio Value (Mil$)
ELI LILLY & CO 8.31 379.95
JOHNSON & JOHNSON 5.01 229.16
ASTRAZENECA PLC 4.22 193.09
UNITEDHEALTH GROUP INC 4.21 192.29
ABBVIE INC 3.58 163.59
ABBOTT LABORATORIES 3.16 144.64
ARGENX SE ADR 2.83 129.15
BOSTON SCIENTIFIC CORP 2.75 125.49
SANOFI SA 2.69 122.94

Stock Holding % of Net Assets

As Of 9/30/2025
Total Issues 83
Avg. P/E 26.72
Avg. P/Book 5.88
Avg. EPS Growth 12.63
Avg. Market Value (Mil $) 188,578

Composition

% of Portfolio
Stocks 99.30
Foreign Stocks 19.96
Cash 0.97
Bonds 0.00
Foreign Bonds 0.00
Preferred 0.00
Convertible 0.00
Other -0.27
Foreign Hedged 0.00

Style Analysis

% of Portfolio
Large Growth NA
Large Value NA
Small Growth NA
Small Value NA
Foreign Stock NA
Emerging Market NA
Precious Metal NA
Intermediate Bond NA
Foreign Bond NA
High Yield Bond NA